[Glitazone - mailing no 3. In response to DMW 49/2007]

Dtsch Med Wochenschr. 2008 Feb;133(6):261-2; author reply 262-3. doi: 10.1055/s-2008-1017510.
[Article in German]
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cardiovascular Diseases / chemically induced*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Hypoglycemic Agents / therapeutic use
  • Prospective Studies
  • Risk Assessment
  • Risk Factors
  • Thiazolidinediones / adverse effects*
  • Thiazolidinediones / therapeutic use

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones